A drug shortage is a quality failure with a body count.
Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.
By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.
The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.
| Drug | Company | Therapeutic area | Availability | Status | Posted |
|---|---|---|---|---|---|
| Rocuronium Bromide InjectionInjection | XGen Pharmaceuticals DJB, Inc. | Anesthesia | Available | Current | 2023-02-15 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Takeda Pharmaceuticals USA Inc. | Psychiatry | Available | Current | 2023-07-14 |
| Lisdexamfetamine Dimesylate Tablet, ChewableTablet, Chewable | Takeda Pharmaceuticals USA Inc. | Psychiatry | Available | Current | 2023-07-14 |
| Lisdexamfetamine Dimesylate Tablet, ChewableTablet, Chewable | Takeda Pharmaceuticals USA Inc. | Psychiatry | Available | Current | 2023-07-14 |
| Lisdexamfetamine Dimesylate Tablet, ChewableTablet, Chewable | Takeda Pharmaceuticals USA Inc. | Psychiatry | Available | Current | 2023-07-14 |
| Promethazine Hydrochloride InjectionInjection | XGen Pharmaceuticals DJB, Inc. | Analgesia/Addiction | Available | Current | 2023-11-21 |
| Rifapentine Tablet, Film CoatedTablet | Sanofi-Aventis U.S. LLC | Anti-Infective | Available | Current | 2020-03-25 |
| Rifampin InjectionInjection | Sanofi-Aventis U.S. LLC | Anti-Infective | Unavailable | Current | 2021-02-17 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Amneal Pharmaceuticals | Psychiatry | Available | Current | 2023-07-14 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Amneal Pharmaceuticals | Psychiatry | Available | Current | 2023-07-14 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Amneal Pharmaceuticals | Psychiatry | Available | Current | 2023-07-14 |
| Methylprednisolone Acetate InjectionInjection | Amneal Pharmaceuticals | Rheumatology | Available | Current | 2021-12-15 |
| Dexmedetomidine Hydrochloride InjectionInjection | Amneal Pharmaceuticals | Anesthesia | Available | Current | 2020-04-10 |
| Emtricitabine Oral SolutionOral Solution | Gilead Sciences, Inc. | Anti-Infective | — | To Be Discontinued | 2026-06-17 |
| Dexmedetomidine Hydrochloride InjectionInjection | Amneal Pharmaceuticals | Anesthesia | Available | Current | 2020-04-10 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Amneal Pharmaceuticals | Psychiatry | Available | Current | 2023-07-14 |
| Methylprednisolone Acetate InjectionInjection | Amneal Pharmaceuticals | Rheumatology | Available | Current | 2021-12-15 |
| Emtricitabine CapsuleCapsule | Gilead Sciences, Inc. | Anti-Infective | — | To Be Discontinued | 2026-06-17 |
| Dexmedetomidine Hydrochloride InjectionInjection | Amneal Pharmaceuticals | Anesthesia | Available | Current | 2020-04-10 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Amneal Pharmaceuticals | Psychiatry | Available | Current | 2023-07-14 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Amneal Pharmaceuticals | Psychiatry | Available | Current | 2023-07-14 |
| Etomidate InjectionInjection | Caplin Steriles, Ltd. | Anesthesia | Available | Current | 2022-10-05 |
| Etomidate InjectionInjection | Caplin Steriles, Ltd. | Anesthesia | Available | Current | 2022-10-05 |
| Etomidate InjectionInjection | Caplin Steriles, Ltd. | Anesthesia | Available | Current | 2022-10-05 |
| Etomidate InjectionInjection | Caplin Steriles, Ltd. | Anesthesia | Available | Current | 2022-10-05 |
Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).